Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...

In May, Pfizer CEO Dr. Albert Bourla defended previous comments HHS officials made about mRNA vaccines. 2 At the time, he called mRNA vaccines the most utilized vaccines in human history. He cited the ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Canadian doctors and scientists also say Kennedy’s false claims and overall disinformation will cause ‘confidence crisis’ ...

US President Donald Trump's administration has announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

According to TipRanks.com, Richter is a 4-star analyst with an average return of 8.8% and a 42.9% success rate. Richter covers the Healthcare sector, focusing on stocks such as Ultragenyx ...

Moderna and MSD are preparing to launch the first phase 3 trial of a messenger RNA (mRNA) cancer vaccine after a study suggested it could be used to treat an aggressive type of skin cancer.